代表的業績 |
- Yamasaki S, et al. Detection of human herpesvirus-8 in peripheral blood mononuclear cells from adult Japanese patients with multicentric Castleman’s disease. Br J Haematol 2003;120:471-477.
- Yamasaki S, et al. Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donors. Bone Marrow Transplant 2003;32:505-510.
- Yamasaki S, et al. Allogeneic peripheral blood stem cell transplantation from two- or three-loci-mismatched related donors in adult Japanese patients with high-risk hematologic malignancies. Bone Marrow Transplant 2004;33:279-289.
- Yamasaki S, et al. Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signaling. Leukemia Res 2004;28:1023-1031.
- Yamasaki S, et al. Infectious complications in chronic graft-versus-host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced- and conventional-intensity conditioning regimens. Transpl Infect Dis.2008;10:252-259.
- Yamasaki S, et al. Development of a method for effective amplification of human adenovirus 40. Arch Virol 2010;155:1059-1068.
- Yamasaki S, et al. Intravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancer. Int J Cancer 2013;133:88-97.
- Yamasaki S, et al. Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens. Int J Hematol 2013; 97: 421-426.
- Yamasaki S, et al. A single intraduodenal administration of human adenovirus 40 vaccine effectively prevents anaphylactic shock. Clin Vaccine Immunol. 2013;20:1508-1516.
- Yamasaki S, et al. Ventricular fibrillation after bortezomib therapy in a patient with systemic amyloidosis. Hematol Reports 2013;5:39-42.
- Yamasaki S, et al. UGT1A1 *6 polymorphism predicts outcome in elderly patients with relapsed or refractory diffuse large B-cell lymphoma treated with carboplatin, dexamethasone, etoposide and irinotecan. Ann Hematol 2015;94:65-69.
- Yamasaki S, et al. Factors prognostic of eligibility for allogeneic HCT among older patients with AML-CR1 and adverse- or intermediate-risk cytogenetics. Ann Hematol. 2015;94:1159-1165.
- Yamasaki S, et al. Dose-adjusted Lenalidomide Combined with Low-dose Dexamethasone Rescues Older Patients with Bortezomib-resistant Multiple Myeloma. Intern Med. 2015;54:1711-1715.
- Yamasaki S, et al. Prophylaxis against Pneumocystis jirovecii pneumonia in patients with adult T-cell lymphoma/leukemia receiving anti-CC chemokine receptor 4 monoclonal antibody. J Infect 2015;71:700-702.
- Yamasaki S, et al. Role of reduced-intensity conditioning allogeneic hematopoietic cell transplantation in older patients with de novo acute myeloid leukemia. Ann Hematol. 2017;96:289-297.
- Yamasaki S, et al. Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine. Ann Hematol. 2017;96:1215-1217.
- Yamasaki S, et al. Therapy-related acute myeloid leukemia and myelodysplastic syndrome after hematopoietic cell transplantation for lymphoma. Bone Marrow Transplant 2017;52:969-976.
- Yamasaki S, et al. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma. Ann Hematol. 2018;97:1445-1452.
- Yamasaki S, et al. Risk of secondary primary malignancies in multiple myeloma patients with or without autologous stem cell transplantation. Int J Hematol. 2019;109:98-106.
- Yamasaki S, et al. Effect of allogeneic stem cell transplantation in patients with minimally differentiated acute myeloid leukemia.Journal of HCT. 2019;8:1-8.
- Yamasaki S, et al. Risk factors and timing of autologous stem cell transplantation for patients with peripheral T-cell lymphoma. Int J Hematol. 2019;109:175-186.
- Yamasaki S, et al. Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory marginal zone lymphoma. Ann Hematol. 2019; 98:1521-1523.
- Yamasaki S, et al. Acquired Hemophilia A Associated with Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus: A Single-Center Case Series in Japan. Diabetes Ther.2019;10:1139-1143.
- Yamasaki S, et al. Phase II Trial Using Romidepsin after Gemcitabine, Dexamethasone, and Cisplatin Therapy in Elderly Transplant-Ineligible Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma: Study Protocol. Acta Med Okayama. 2019;73:469-474.
- Yamasaki S, et al. Effect of allogeneic hematopoietic cell transplantation for patients with T-prolymphocytic leukemia: a retrospective study from the Adult Lymphoma Working Group of the Japan Society for hematopoietic cell transplantation. Ann Hematol.2019;98:2213-2220.
- Yamasaki S, Kada A, Nagai H, Yoshida I, Choi I, Miyata Y, Miyazawa Y, Saito A, Iwasaki H. Rituximab-mediated complement-dependent cytotoxicity enhanced by gemcitabine in older patients with previously rituximab-treated diffuse large B-cell lymphoma: Study Protocol.Kurume Med J. 2020;66:37-42.
- Yamasaki S, et al. Better disease control before allogeneic stem cell transplantation is crucial to improve the outcomes of transplantation for acute myeloid leukemia patients with extramedullary disease. Bone Marrow Transplant. 2020;55:249-252.
- Yamasaki S, et al. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma. Int J Hematol. 2020;112:74-83.
- Yamasaki S, et al. Effect of allogeneic HCT from unrelated donors in AML patients with intermediate- or poor-risk cytogenetics: A retrospective study from the Japanese Society for HCT. Ann Hematol.2020;99:2927-2937.
- Yamasaki S, et al. Comparison of prognostic scores in transplant-ineligible patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma: a retrospective study from the National Hospital Organization in Japan.Leuk Lymphoma. 2021;62:819-827.
- Yamasaki S, et al. Phase II study of dose-adjusted gemcitabine, dexamethasone, cisplatin, and rituximab in elderly relapsed diffuse large B-cell lymphoma patients. eJHaem. 2020;1:507–516.
- Yamasaki S, et al. Clinical impact of comprehensive geriatric assessment in patients aged 80 years and older with diffuse large B-cell lymphoma receiving rituximab-mini-CHOP: A single-institute retrospective study.Euro Geriatric Med 2022;13:195-201.
- Yamasaki S, et al. Clinical impact of bendamustine exposure on lymphopenia risk after bendamustine and rituximab combination therapy for follicular lymphoma: a single-institute retrospective study. Ann Hematol 2022; 101:209-211.
- Yamasaki S, Tokunou T Horiuchi T.Factors Associated with Discontinuation of Statin Therapy in Patients with Lymphoma Aged 80 Years and Older: A Retrospective Single-Institute Study.Drugs Real World Outcomes 2022;9:569-575
- Yamasaki S, Kamezaki K, Ito Y, Horiuchi T.Bisphosphonate Use for Glucocorticoid-Induced Osteoporosis in Elderly Patients with Immune Thrombocytopenia Receiving Prolonged Steroid Therapy: A Single Institute Retrospective Study.Hematol Rep. 2022 Sep 19;14(3):276-285.
- Yamasaki S, Tokunou T, Maeda T, Horiuchi T.Hot spring bathing is associated with a lower prevalence of hypertension among Japanese older adults: a cross-sectional study in Beppu.Sci Rep. 2022 Nov 14;12(1):19462.
- Yamasaki S, Maeda T, Horiuchi T.Association between habitual hot spring bathing and depression in Japanese older adults: A retrospective study in Beppu.Complementary Therapies in Medicine. 2023;72:102909.
- Yamasaki S, Horiuchi Hypoxia-Inducible Factor-Prolyl-Hydroxylase and Sodium-Glucose Cotransporter 2 Inhibitors for Low-Risk Myelodysplastic Syndrome-Related Anemia in Patients with Chronic Kidney Disease: A Report of Three Cases.Hematol Rep. 2023 Mar 6;15(1):180-187.
- Yamasaki S, et al. Efficacy and safety of allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients aged > 65 years with unfavorable cytogenetics. Ann Hematol. 2023;102:1549-1559.
- Yamasaki S, et al.Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective. Ann Hematol. 2023;102:1645-1656.
- Yamasaki S. Feasibility of Quality of Life Assessment in Patients with Lymphoma Aged ≥80 Years Receiving Reduced-Intensity Chemotherapy: A Single-Institute Study. Hematol Rep 2024, 16(1), 1-10.
- Yamasaki S, Tokunou T, Maeda T, Horiuch T. Night-Time Hot Spring Bathing Is Associated with a Lower Systolic Blood Pressure among Japanese Older Adults: A Single-Institution Retrospective Cohort Study. Geriatrics 2024, 9(1),2.
|